A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination

Agriculture & Biology

• amygdala 41%
• brain 37%
• dropouts 33%
• metabolism 31%
• positron-emission tomography 17%
• sleep disorders 16%
• combination drug therapy 15%
• behavior disorders 14%
• rating scales 14%
• magnetic resonance imaging 14%
• anxiety 12%
• morbidity 11%
• drug therapy 10%
• interviews 10%
• cortex 9%
• experimental design 8%
• pretreatment 8%
• protocols 7%
• sampling 7%

Medicine & Life Sciences

• olanzapine-fluoxetine combination 100%
• Treatment-Resistant Depressive Disorder 72%
• Brain 26%
• Amygdala 17%
• Depression 11%
• Psychological Power 11%
• Sample Size 10%
• Therapeutics 8%
• Sleep Initiation and Maintenance Disorders 6%
• Drug Combinations 6%
• Gyrus Cinguli 6%
• Positron-Emission Tomography 5%
• Mental Disorders 4%
• Psychiatry 4%
• Anxiety 4%
• Interviews 3%
• Magnetic Resonance Imaging 3%
• Databases 3%
• Morbidity 3%
• Mortality 3%

Chemical Compounds

• Pharmacological Metabolism 41%
• Metabolic 17%
• Positron 12%
• Biological Property 10%
• Heterogeneity 9%
• Disorder 9%
• Drug 5%